Skip to content

Aptalis Pharma Inc

company.status.inactive

CIK 1444570fmd_0HHTT6GQJFRW7RS7PWWTZ36H9PManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Oct 01, 2008 to Dec 31, 2011, 7 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011
Total revenues417355470
Research and development363258
Selling, general and administrative123114143
Operating income34(104)(66)
Interest expense706589
Interest and investment income010
Other non-operating income (expense)(66)(56)(117)
Income before taxes(32)(159)(184)
Income tax expense(24)114
Net income from continuing operations(8)(170)(188)
Net income(8)(170)(188)
Aptalis Pharma Inc financial statements · FinancialMD